Skip to content

BeyondSpring Inc.

BYSI· NasdaqCore metricsCIK 1677940

Pharmaceutical preparations551 peers

Last sale
Nov 11, 2026 · +6.66%
Market cap
$26.58M
41.41M shares
Filings
266
$0.00
Q3 2026
$50.79M
Q3 2026N/M FY25 yoy
-$2.06M
Q3 2026N/M FY25 yoy
-$10.65M
Q3 2026derivedN/M FY25 yoy
-$0.02
Q2 2026N/M FY21 yoy
$580.00K
Q3 2026+1.5% FY25 yoy
$26.58M
0.6×
—
1.7×
-60.76%
—

Twelve months to Sep 30, 2026 · derived

Price

$0.64267.08%$1.308past year
Nov 11, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2025
$1.35M0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$0reported
FY 20242024-12-31$0reported
FY 20232023-12-31$0reported
FY 20222022-12-31$1,351,000reported
FY 20212021-12-31$1,351,000reported
FY 20202020-12-31$180,000reported
FY 20192019-12-31$0reported
FY 20182018-12-31$0reported
FY 20172017-12-31$0reported
FY 20162016-12-31$0reported
FY 20152015-12-31$0reported
FY 20142014-12-31$0reported

Segments

Revenue by Segments, FY2020 to FY2023FY2020TPD Platform · FY2020 · $180.00KFY2021TPD Platform · FY2021 · $1.35MFY2022TPD Platform · FY2022 · $1.35MFY2023TPD Platform · FY2023 · $1.75M
LineFY2023ShareChange
TPD Platform$1.75M—+29.6%
Plinabulin Pipeline$0.00——
Total$0.00

From the 20-F filed Apr 29, 2024BYSI

Pharmaceutical preparations

BeyondSpring Inc. is the 367th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

BeyondSpring Inc. · CIK 1677940 · Engraved from SEC EDGAR